Here is another good news/bad news column about the 112th Congress.

Testimony before the Food and Drug Administration on September 13, 2002, on how the FDA can assure that its controls over commercial speech conforms to Supreme Court decisions.

Testimony submitted by Randall Lutter and Elizabeth Irwin before the U.S. Food and Drug Administration in September 2002.

With fakes of the cancer drug Avastin popping up in U.S. clinics in the past few months, patients are naturally worried about whether their medicines are safe.  Considering eighty percent of the ingredients in U.S. medicines come from overseas – mostly from China and India because their products are generally...

In an attempt to protect poor, uninsured and underinsured Americans from unsafe drugs, we are making sure that some go without drugs completely. It is time the law was changed.

Knowing where all our ingredients come from is the first step toward improving drug quality.

AEI-Brookings Joint Center senior fellow Judyth Pendell interviews FDA commissioner Mark B. McClellan about liability, innovation, and policy objectives.